Table 3. Intensity of immuno-staining of different antigens in epithelial and stromal cells of prostatic adenocarcinomas without stromal reactivity (group-1) and with intense stromal reactivity (group-2).
Groups | ||
---|---|---|
Antigens | Group 1 (n=20) | Group 2 (n=20) |
α-actin | 3 (80.3%)* | 2 (69.0%) |
Vimentin | 2 (61.4%) | 3 (92.4%)* |
IGF-1 | 2 (57.6%) | 3 (96.8%)* |
MMP-2 | 2 (67.3%) | 3 (89.7%)* |
FGF-2 | 2 (62.7%) | 3 (91.5%)* |
C-Myc | 2 (65.5%) | 3 (93.3%)* |
PSCA | 2 (56.5%) | 3 (85.8%)* |
AR | 1 (30.9%) | 2 (59.5%)* |
Erα | 2 (39.7%) | 3 (77.9%)* |
Erβ | 2 (38.6%)* | 1 (26.5%) |
0 (absence of immunoreactivity), 0% of positive epithelial and/or stromal cells; 1 (weak immunoreactivity), 1–35% of positive epithelial and/or stromal cells; 2 (moderate immunoreactivity), 36–70% of positive epithelial and/or stromal cells; 3 (intense immunoreactivity), >70% of positive epithelial and/or stromal cells.